Diekema Douglas S, Wilfond Benjamin S
Perspect Biol Med. 2016;58(3):328-31. doi: 10.1353/pbm.2016.0007.
We argue that medical decisions on behalf of children should be made with the welfare of the child as the primary interest, that parents should generally be allowed to determine which options optimize the interests of their child, and that those decisions should be formally challenged only when the parental decision places the child at substantial risk of a serious harm as compared to the option favored by the health-care provider. In situations where moral ambiguity exists and no possible solution could unequivocally be declared the right or good one, a parental decision favoring one or the other of the reasonable options should be supported. Parents should be provided with adequate time to consider information provided and weigh the various options presented. If parents find themselves unable to make a decision, we suggest several strategies for shared decision-making. Finally, we recommend setting time points for reassessment of the situation following each therapeutic change to allow reevaluation of whether the chosen path should be altered.
我们认为,代表儿童做出的医疗决策应以儿童的福祉为首要利益,通常应允许父母决定哪些选择最能优化其子女的利益,并且只有当父母的决定使儿童面临与医疗服务提供者所青睐的选择相比严重伤害的重大风险时,这些决定才应受到正式质疑。在存在道德模糊性且无法明确宣布任何可能的解决方案是正确或良好的情况下,应支持父母对合理选择中的某一个的决定。应给予父母足够的时间来考虑所提供的信息并权衡所提出的各种选择。如果父母发现自己无法做出决定,我们建议了几种共同决策的策略。最后,我们建议在每次治疗改变后设定重新评估情况的时间点,以便重新评估是否应改变所选择的路径。